XML 38 R77.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY - Stock options (Details) - USD ($)
12 Months Ended
Aug. 07, 2019
Oct. 02, 2017
Aug. 07, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
STOCKHOLDERS' EQUITY            
Number of Options, Grants   37,500   653,210 732,869  
Number of Options, Exercised       15,000 63,190  
Stock options [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Outstanding at Beginning of Year       3,569,000 4,804,000  
Number of Options, Grants       653,000 733,000  
Number of Options, Exercised       15,000 63,000  
Number of Option, Forfeited/cancelled/expired/settled       10,000 1,905,000  
Number of Options, Balance at End of Year       4,197,000 3,569,000 4,804,000
Number of Options, Vested and expected to vest       4,145,000    
Number of Options, Unvested       822,000    
Number of Options, Exercisable       3,375,000    
Weighted-Average Exercise Price, Outstanding at Beginning of Year (in dollars per share)       $ 2.12 $ 1.89  
Weighted-Average Exercise Price, Grants (in dollars per share)       2.17 1.81  
Weighted-Average Exercise Price, Exercised (in dollars per share)       1.90 1.41  
Weighted-Average Exercise Price, Forfeited/cancelled/expired/settled (in dollars per share)       1.90 1.43  
Weighted-Average Exercise Price, Balance at End of Year (in dollars per share)       2.13 $ 2.12 $ 1.89
Weighted-Average Exercise Price, Vested and expected to vest (in dollars per share)       2.13    
Weighted-Average Exercise Price, Unvested (in dollars per share)       2.11    
Weighted-Average Exercise Price, Exercisable (in dollars per share)       $ 2.13    
Weighted-Average Remaining Contractual Term, Outstanding (in years)       6 years 8 months 12 days 7 years 2 months 9 days 4 years 10 months 24 days
Weighted-Average Remaining Contractual Term, Vested and expected to vest (in years)       6 years 8 months 5 days    
Weighted-Average Remaining Contractual Term, Unvested (in years)       9 years 1 month 17 days    
Weighted-Average Remaining Contractual Term, Exercisable (in years)       6 years 1 month 10 days    
Aggregate Intrinsic Value, Outstanding       $ 255,000 $ 130,000 $ 795,000
Aggregate Intrinsic Value, Vested and expected to vest       255,000    
Aggregate Intrinsic Value, Unvested       0    
Aggregate Intrinsic Value, Exercisable       $ 255,000    
Common Class D [Member] | Stock options [Member] | Chairperson [Member] | Share-based Compensation Award, Tranche One [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants     199,836      
Common Class D [Member] | Stock options [Member] | Chairperson [Member] | Share-based Compensation Award, Tranche Two [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants     210,937      
Common Class D [Member] | Stock options [Member] | Chief Executive Officer and President [Member] | Share-based Compensation Award, Tranche One [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants 333,059          
Common Class D [Member] | Stock options [Member] | Chief Executive Officer and President [Member] | Share-based Compensation Award, Tranche Two [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants 351,562          
Common Class D [Member] | Stock options [Member] | Chief Financial Officer [Member] | Share-based Compensation Award, Tranche One [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants     114,035      
Common Class D [Member] | Stock options [Member] | Chief Financial Officer [Member] | Share-based Compensation Award, Tranche Two [Member]            
STOCKHOLDERS' EQUITY            
Number of Options, Grants     120,370